Operating profit before deduction of amortization: Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics (NMRA) is implementing big data analytics for precision psychiatric treatment. EBITDA volatility visualizes this approach, where the 0.00 mark serves as the current indicator. The company is scaling its portfolio of precision drugs to capture the CNS market. Meanwhile, business resilience relies on patent protection and the successful completion of rigorous FDA trials.
Neumora Therapeutics, Inc. - analytical breakdowns and key metrics (NMRA)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Total Debt to Capital Neumora Therapeutics|NMRA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Neumora|NMRA - Company Total Debt|Debt to Book Capital Neumora Therapeutics|NMRA - Company Long-Term Debts|Company Short-Term Loans and Borrowings Neumora Therapeutics|Immediate Liquidity neumoratx.com
- earnings and market multiples details:
NMRA - Company Net Income|Expected Net Income Neumora Therapeutics|NMRA - P/E Multiple|Forward P/E Multiple neumoratx.com|NMRA - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Neumora Therapeutics|NMRA - Operating profit EBITDA|Net earnings per one share for the last twelve months Neumora Therapeutics|NMRA - Net earnings per share for the last 12 months|Quarterly EPS earnings growth neumoratx.com|NMRA - Net earnings per share growth this year|Projected earnings per share increase next year Neumora Therapeutics
- sales and revenue data:
Fundamental company valuation:Neumora Corp NMRA
This metric measures the volume of cash flow from operating activities before depreciation and interest, determining the business's internal capacity to generate liquidity. For Neumora Therapeutics (NMRA), this metric reflects the efficiency of neurobiological developments, accounting for chemical waste disposal costs and laboratory energy modernization, which clearly demonstrates the operating profit history in monetary terms through the dynamics of extremes.
Who Neumora Therapeutics competes with
Operating profit EBITDA Biogen Idec BIIB|NBIX - Profit before payment of interest, taxes and amortization|regencellbioscience.com (RGC) - Operating profit before deduction of amortization|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization ACADIA Pharma (ACAD)|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|VKTX: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SUPN|Operating profit EBITDA catalystpharma.com (CPRX)|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Amylyx Corp - Company profit before taxes, interest and amortization|TRVI: Operating profit EBITDA|praxismedicines.com - Income before deduction of interest, taxes and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Profit before interest, taxes and amortization CeriBell Inc CBLL|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|NGNE - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACIU|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Scilex Holding Company, Inc. (SCLX)|Operating profit before deduction of amortization TVGN|Operating profit EBITDA Alpha Cognition Corp|Operating profit before deduction of amortization CGTX (Cognition Therapeutics, Inc.)|Company profit before taxes, interest and amortization IKT|Operating profit EBITDA SAVA (Cassava)|Operating income before deduction of amortization Assertio Holdings (ASRT)|Coya - Operating profit EBITDA|Vistagen Therapeutics (VTGN) - Operating profit before deduction of amortization|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|ABOS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization CervoMed Inc|Operating profit before amortization ATHE (Alterity Therapeutics Ltd)|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|Operating profit before deduction of amortization pepgen.com PEPG|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|Income before deduction of interest, taxes and amortization RLMD|Annovis Bio Corp - Operating profit EBITDA|GRCE - Operating profit EBITDA|Firefly Neuroscience, Inc (AIFF) - Profit before payment of interest, taxes and amortization|Operating profit before amortization KLTO|NRSN (NeuroSense Therapeutics Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Reviva Pharmaceuticals Holdings Inc. RVPH|Operating profit before deduction of amortization MTVA (MetaVia Inc)|Operating profit EBITDA NeurAxis Inc (NRXS)|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Income before deduction of interest, taxes and amortization PASG|NEUP - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Minerva Neurosciences Inc|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ADXN|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Cyclerion CYCN|Operating profit before deduction of amortization PTIX (Protagenic Therapeutics)|Operating profit EBITDA pasitheaclinics.com (KTTA)|Profit before payment of interest, taxes and amortization Cortigent CRGT|ATXI - Operating profit before deduction of amortization|BCLI - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Operating profit EBITDA Longboard|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SAGE (Sage Therapeutics Inc.)|Neurotrope - Operating profit EBITDA|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|VIGL: Operating profit EBITDA|Profit before interest, taxes and amortization anewmeds.com (WENA)|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
